AEGiS-UNAIDS: Scientists come together for the AIDS Vaccine Conference 2009 UNAIDSImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow


Scientists come together for the AIDS Vaccine Conference 2009

UNAIDS - 19 October 2009


The yearly AIDS Vaccine Conference opened in Paris today. High on the agenda are discussions on the progress made in vaccine development and implications of trial results for the future. In a keynote address to the conference, UNAIDS Executive Director Mr Michel Sidibe said access and affordability were the first challenges towards building an effective AIDS response.

Mr Sidibe spoke about positive developments related to the AIDS vaccine research field. The recent results in Thailand have given hope to the many scientists who are working on finding a safe and highly effective HIV vaccine. These efforts demonstrate the vigour and momentum of the collective global effort to deliver on the promise of AIDS vaccines, said Mr Sidibe.

A ready to use vaccine against HIV could be more than a decade away, but when it does become available, it needs to be financed as a public good that is accessible for all.

Michel Sidibe, UNAIDS Executive Director

The UNAIDS Head also spoke of the challenge in creating conducive conditions for massive uptake of an effective AIDS vaccine. Antiretroviral treatment has been around since 1996, but real access to treatment only came about after public pressure put on world leaders û as a result the prices of medicines came down giving millions of people living with HIV in developing countries access to treatment.

Today, AIDS activists are repeating these efforts to reduce prices, this time for second line antiretroviral medicines.

ôA ready to use vaccine against HIV could be more than a decade away, but when it does become available, it needs to be financed as a public good that is accessible for all,ö Mr Sidibe said, ôMeanwhile we have to redouble our combination HIV prevention efforts to stop the continuing tide of new HIV infections.ö

AIDS Vaccine 2009 will bring together established and young research scientists, with clinicians, epidemiologists and public health experts aimed at sharing experience and scientific advances and enhancing collaborations.

The first AIDS Vaccine Conference, organized by the Global HIV Vaccine Enterprise, was held in Paris in the year 2000 with the aim of advancing the field of HIV vaccine research through discussion, exchange and learning. The annual meeting is now seen as the leading forum for exchange of scientific information relating to the difficult challenge of developing an effective vaccine against HIV. It will conclude on 22 October.

Resources:

Policy and guidance:

Vaccines - http://www.unaids.org/en/PolicyAndPractice/ScienceAndResearch/Vac cines/default.asp

Science and research - http://www.unaids.org/en/PolicyAndPractice/ScienceAndResearch/def ault.asp

Press centre:

Read UNAIDS Executive Director's speech at the AIDS Vaccine conference (19 October 2009) - http://data.unaids.org/pub/SpeechEXD/2009/20091019_sp_paris_scien tistsasactivists_fnl_en.pdf

Shifting scientific, health priorities and global economic downturn: Impact Investment in HIV prevention R&D - http://www.unaids.org/en/KnowledgeCentre/Resources/PressCentre/Pr essReleases/2009/20090720_PR_Funding.asp

Feature stories:

OPINION: HIV vaccine--a public good to right a global wrong (02 October 2009) - http://www.aegis.org/news/unaids/2009/UN091001.html

Fifth African AIDS Vaccine Programme (AAVP) Forum (19 June 2009) - http://www.unaids.org/en/Conferences/2009/20090619_FifthAfricaAID S.asp

External links:

AIDS Vaccine Conference 2009 - http://www.hivvaccineenterprise.org/conference/2009/index.aspx

International AIDS Vaccine Initiative - http://www.iavi.org/Pages/home.aspx
091019
UN091014


Copyright © 2009 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .